Uniting science, technology and talent to get ahead of disease together.
GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology).
Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired, encouraged and challenged to be the best they can be. A place where they can be themselves – feeling welcome, valued, and included. Where they can keep growing and look after their wellbeing. So, if you share our ambition, join us at this exciting moment in our journey to get Ahead Together.
Immunological Toxicology is part of the Non-clinical Safety (NCS) department with in GSK R&D Business Unit. NCS aims to characterize, understand, and explain the biological mechanisms of the Safety of new medicines and to translate this knowledge for project teams, patients, prescribers, and regulatory agencies.
Immunolgical Toxicology specifically develops and executes testing strategies to investigate immunotox consequences of on-target and/or off-target engagement of compounds. We provide timely, comprehensive, and well-integrated assessments of immunotoxicity potential and risk at all phases of drug development and regulatory submissions. We support customized immunotoxicology testing on in-house and outsourced in vivo toxicology studies and continuously develop and improve in vitro and in vivo methods to assess immunotoxicity.
We are located at the Upper Providence Site in Collegeville, PA.
We are seeking a 6-month co-op student who is interested in learning and utilizing “state of the art” equipment for evaluating drug-induced effects on the immune system. The co-op student will be involved with ongoing Immunologic Toxicology projects evaluating Immune stimulation and disregulation utilizing current immunologic methods such as flow cytometry and cell based assays on samples obtained from in vitro and in vivo studies.
This job posting is for a temporary role as an employee of Atrium on assignment at GSK. The individual selected for this role will be offered the role as an employee of Atrium; compensation, medical benefits, fringe benefits and other terms and conditions of employment shall be presented by Atrium upon offer. The pay rate range provided is a reasonable estimate of the anticipated compensation range for this job at the time of posting. The actual pay rate will be based on several factors, including educational degree obtained.
In addition, this role will be eligible for overtime pay, in accordance with federal and state requirement.
Interested in learning more? Register now on our digital learning platform (GSK Get Ahead - Connectr) where you can access interview and assessment hints and tips, speak to a mentor and learn more about life at GSK.
Software Powered by iCIMS
www.icims.com